Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03741881 · ClinicalTrials.gov registry record
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
A clinical trial, sponsored by Novo Nordisk A/S.
- Completed
- Registry status
- 231
- Enrollment target
NCT03741881: Completed study, sponsored by Novo Nordisk A/S.
NCT03741881 is a clinical trial that has completed, run by Novo Nordisk A/S. The registered enrollment target is 231 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03741881 has completed, sponsored by Novo Nordisk A/S.
- COMPLETED
- Registry status
- 231 participants
- Enrollment target
Study Summary
This study will collect data on bleeds and data related to quality of life in people with severe congenital (a disease existing from birth) haemophilia A and B, with or without inhibitors. The aim for the study is to look at the number of bleeds when on usual treatment for haemophilia. Participants will be asked to keep an electronic diary to track the number of bleeds and the treatment of their bleeds. Participants will be asked to wear an activity tracker on their wrist to capture their level of activity every day for up to 12 weeks. While taking part in this study, participants will keep getting their usual treatment as given to them by their doctor. All study visits at the clinic are done in the same way as the participants are used to. In the time between the participants' visits to the clinic, the study staff at the clinic may call or email the participant. The study will last for about 2½ years.
Primary Outcome
Count of treated bleeding episodes
Interventions
- OTHER No treatment given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2018-12-18 |
| Est. Completion | 2021-10-25 |
What the finished NCT03741881 record still lists
NCT03741881 is an observational study that tracks outcomes without assigning an intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No treatment given is the first listed.
NCT03741881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03741881 about?
NCT03741881 is a clinical study titled "A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)". This study will collect data on bleeds and data related to quality of life in people with severe congenital (a disease existing from birth) haemophilia A and B, with or without inhibitors. The aim for the study is to look at the number of bleeds when on usual treatment for haemophilia. Participants ...
What is the current status of trial NCT03741881?
This trial is currently completed. The enrollment target is 231 participants. The study started on 2018-12-18. Estimated completion is 2021-10-25.
What interventions are being tested in trial NCT03741881?
The interventions under investigation include: No treatment given (OTHER).
Who is sponsoring clinical trial NCT03741881?
This trial is sponsored by Novo Nordisk A/S, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI